question: Does natalizumab improve disease course of secondary progressive multiple sclerosis?
answer: No. Atalizumab treatment for secondary progressive multiple sclerosis did not reduce progression on the primary multicomponent disability endpoint in part 1, but it did reduce progression on its upper-limb component.